Jeffery Thompson's most recent trade in Anika Therapeutics Inc. was a trade of 6,500 Common Stock done . Disclosure was reported to the exchange on June 14, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Anika Therapeutics Inc. | Jeffery Scott Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,500 | 31,575 (0%) | 0% | 0 | Common Stock | |
Anika Therapeutics Inc. | Jeffery Scott Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 7,954 | 25,075 (0%) | 0% | 0 | Common Stock | |
Anika Therapeutics Inc. | Jeffery Scott Thompson | Director | Purchase of securities on an exchange or from another person at price $ 24.66 per share. | 11 Mar 2022 | 2,000 | 17,121 (0%) | 0% | 24.7 | 49,318 | Common Stock |
Anika Therapeutics Inc. | Jeffery Scott Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 4,172 | 15,121 (0%) | 0% | 0 | Common Stock |